HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Sanofi divesting Nina Ricci

This article was originally published in The Rose Sheet

Executive Summary

Sanofi divesting Nina Ricci: Sale of the fragrance and fashion house expected to be completed by the end of the year. Under a contract between the two companies, Sanofi is required to purchase a 100% interest in Nina Ricci before the end of 1997, unless it can first divest its stake. Sanofi holds a 57% interest in Ricci and commands 49% of the firm's voting power. Explaining the upcoming sale, the Paris-based company said Ricci sales have not been in line with expectations. Sanofi confirmed that one interested party in the deal is Barcelona-based Antonio Puig S.A., the privately owned parent of the Paco Rabanne fragrances and designer label. At a Nov. 20 meeting with securities analysts, Sanofi projected sales for the beauty business worldwide would total roughly $690 mil. The Nina Ricci business is expected to generate approximately $173 mil. of that total, and Yves Rocher, in which Sanofi also holds a partial stake, is predicted to bring in revenues of just under $3 mil....
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004867

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel